<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To compare neuroprotective effects of <z:chebi fb="0" ids="6456">lidocaine</z:chebi> and <z:chebi fb="0" ids="8430">procaine</z:chebi> against ischemic insult, intracellular recordings were made from rat hippocampal CA1 pyramidal neurons in slice preparations </plain></SENT>
<SENT sid="1" pm="."><plain>Superfusion of the slices with oxygen- and <z:chebi fb="105" ids="17234">glucose</z:chebi>-deprived medium (in vitro <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>) produced a rapid depolarization 6 min from the <z:hpo ids='HP_0003674'>onset</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>When oxygen and <z:chebi fb="105" ids="17234">glucose</z:chebi> were reintroduced, the membrane depolarized further until it reached 0 mV, and thereafter the membrane showed no functional recovery </plain></SENT>
<SENT sid="3" pm="."><plain>Pretreatment with <z:chebi fb="0" ids="6456">lidocaine</z:chebi> (10 microM), but not <z:chebi fb="0" ids="8430">procaine</z:chebi> (50 microM), restored the membrane potential after the reintroduction of oxygen and <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="6456">Lidocaine</z:chebi>, compared to <z:chebi fb="0" ids="8430">procaine</z:chebi>, significantly inhibited the reduction in both tissue ATP content and <z:chebi fb="0" ids="5086">flavoprotein</z:chebi> fluorescence during and after in vitro <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>Under electron microscopy, only <z:chebi fb="0" ids="6456">lidocaine</z:chebi> well preserved the structure of mitochondria in the CA1 pyramidal cell body </plain></SENT>
<SENT sid="6" pm="."><plain>Extracellular recordings revealed that <z:chebi fb="0" ids="8430">procaine</z:chebi> reduced the field postsynaptic potential whereas <z:chebi fb="0" ids="6456">lidocaine</z:chebi> augmented it </plain></SENT>
<SENT sid="7" pm="."><plain>Both drugs reduced the presynaptic volley dose-dependently </plain></SENT>
<SENT sid="8" pm="."><plain>Neither <z:chebi fb="0" ids="6456">lidocaine</z:chebi> nor <z:chebi fb="0" ids="8430">procaine</z:chebi> significantly affected a rapid rise of the intracellular <z:chebi fb="0" ids="29108">Ca2+</z:chebi> level produced by in vitro <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the CA1 region </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the results suggest that the neuroprotective <z:chebi fb="0" ids="6456">lidocaine</z:chebi> action is due to the protection of the mitochondria to maintain the tissue ATP content during and after in vitro <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
</text></document>